{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T01:39:48Z","timestamp":1792028388323,"version":"4.4.0"},"reference-count":70,"publisher":"BMJ","issue":"6","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Br J Ophthalmol"],"published-print":{"date-parts":[[2023,6]]},"abstract":"<jats:p>Radiation is a commonly used treatment modality for head and neck as well as CNS tumours, both benign and malignant. As newer oncology treatments such as immunotherapies allow for longer survival, complications from radiation therapy are becoming more common. Radiation-induced optic neuropathy is a feared complication due to rapid onset and potential for severe and bilateral vision loss. Careful monitoring of high-risk patients and early recognition are crucial for initiating treatment to prevent severe vision loss due to a narrow therapeutic window. This review discusses presentation, aetiology, recent advances in diagnosis using innovative MRI techniques and best practice treatment options based on the most recent evidence-based medicine.<\/jats:p>","DOI":"10.1136\/bjo-2022-322854","type":"journal-article","created":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T19:11:40Z","timestamp":1669230700000},"page":"743-749","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":20,"title":["Radiation-induced optic neuropathy: a review"],"prefix":"10.1136","volume":"107","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2172-2120","authenticated-orcid":false,"given":"Andrew R","family":"Carey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandi R","family":"Page","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,11,23]]},"reference":[{"key":"2023051902150749000_107.6.743.1","doi-asserted-by":"publisher","DOI":"10.1177\/0194599814535183"},{"key":"2023051902150749000_107.6.743.2","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4103\/0974-620X.149901","article-title":"Role of total dose and hyperfractionation in reducing risk of radiation-induced optic neuropathy","volume":"8","author":"Kumre","year":"2015","journal-title":"Oman J Ophthalmol"},{"key":"2023051902150749000_107.6.743.3","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ijrobp.2019.10.024","article-title":"Optimizing whole brain radiation therapy dose and fractionation: Results from a prospective phase 3 trial (NCCTG N107C [Alliance]\/CEC.3)","volume":"106","author":"Trifiletti","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2023051902150749000_107.6.743.4","doi-asserted-by":"crossref","unstructured":"Dale RG . A graphical method to simplify the application of the linear-quadratic dose\u2013effect equation to fractionated radiotherapy. Br J Radiol 1985;59:A707.","DOI":"10.1259\/0007-1285-59-707-1111"},{"key":"2023051902150749000_107.6.743.5","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30441-2"},{"key":"2023051902150749000_107.6.743.6","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.46.0410"},{"key":"2023051902150749000_107.6.743.7","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.02767"},{"key":"2023051902150749000_107.6.743.8","first-page":"409","article-title":"Bevacizumab for pediatric radiation necrosis","volume":"7","author":"Baroni","year":"2020","journal-title":"Neurooncol Pract"},{"key":"2023051902150749000_107.6.743.9","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.radonc.2018.11.013","article-title":"Carotid stenosis prevalence after radiotherapy in nasopharyngeal carcinoma: a meta-analysis","volume":"133","author":"Liao","year":"2019","journal-title":"Radiother Oncol"},{"key":"2023051902150749000_107.6.743.10","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/j.ophtha.2020.05.003","article-title":"Immune checkpoint inhibitor-associated optic neuritis","volume":"127","author":"Francis","year":"2020","journal-title":"Ophthalmology"},{"key":"2023051902150749000_107.6.743.11","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2014.00024","article-title":"Biological response of cancer cells to radiation treatment","volume":"1","author":"Baskar","year":"2014","journal-title":"Front Mol Biosci"},{"key":"2023051902150749000_107.6.743.12","doi-asserted-by":"crossref","first-page":"4918","DOI":"10.1007\/s12035-017-0695-z","article-title":"Loss of pericytes in radiation necrosis after glioblastoma treatments","volume":"55","author":"Lee","year":"2018","journal-title":"Mol Neurobiol"},{"key":"2023051902150749000_107.6.743.13","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(82)34611-4"},{"key":"2023051902150749000_107.6.743.14","doi-asserted-by":"crossref","first-page":"e727","DOI":"10.1111\/aos.13797","article-title":"Retinal perfusion changes in radiation retinopathy","volume":"96","author":"Rose","year":"2018","journal-title":"Acta Ophthalmol"},{"key":"2023051902150749000_107.6.743.15","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00795-015-0123-2","article-title":"Delayed brain radiation necrosis: pathological review and new molecular targets for treatment","volume":"48","author":"Furuse","year":"2015","journal-title":"Med Mol Morphol"},{"key":"2023051902150749000_107.6.743.16","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13215327","article-title":"Assessment of radiation-induced optic neuropathy in a multi-institutional cohort of chordoma and chondrosarcoma patients treated with proton therapy","volume":"13","author":"K\u00f6the","year":"2021","journal-title":"Cancers"},{"key":"2023051902150749000_107.6.743.17","article-title":"Long-Term evaluation and normal tissue complication probability (Ntcp) models for predicting radiation-induced optic neuropathy after intensity-modulated radiation therapy (IMRT) for nasopharyngeal carcinoma: a large retrospective study in China","volume":"2022","author":"Wu","year":"2022","journal-title":"J Oncol"},{"key":"2023051902150749000_107.6.743.18","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1080\/08820538.2017.1346133","article-title":"Factors associated with occurrence of radiation-induced optic neuropathy at \"safe\" radiation dosage","volume":"33","author":"Doroslova\u010dki","year":"2018","journal-title":"Semin Ophthalmol"},{"key":"2023051902150749000_107.6.743.19","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ijrobp.2014.10.011","article-title":"Dose-volume relationships associated with temporal lobe radiation necrosis after skull base proton beam therapy","volume":"91","author":"McDonald","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2023051902150749000_107.6.743.20","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/APO.0000000000000271","article-title":"Prophylactic intravitreal bevacizumab after plaque radiotherapy for uveal melanoma: analysis of visual acuity, tumor response, and radiation complications in 1131 eyes based on patient age","volume":"9","author":"Chang","year":"2020","journal-title":"Asia Pac J Ophthalmol"},{"key":"2023051902150749000_107.6.743.21","doi-asserted-by":"publisher","DOI":"10.1016\/0167-8140(94)90005-1"},{"key":"2023051902150749000_107.6.743.22","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/0360-3016(94)90346-8","article-title":"Radiation optic neuropathy after megavoltage external-beam irradiation: analysis of Time-dose factors","volume":"30","author":"Parsons","year":"1994","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2023051902150749000_107.6.743.23","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1177\/1533034617711613","article-title":"Evaluation of the radiation Dose-Volume effects of optic nerves and chiasm by psychophysical, electrophysiologic tests, and optical coherence tomography in nasopharyngeal carcinoma","volume":"16","author":"Ozkaya Akagunduz","year":"2017","journal-title":"Technol Cancer Res Treat"},{"key":"2023051902150749000_107.6.743.24","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.radonc.2019.02.003","article-title":"Radiation-Induced optic neuropathy after stereotactic and image guided intensity-modulated radiation therapy (IMRT)","volume":"134","author":"Brecht","year":"2019","journal-title":"Radiother Oncol"},{"key":"2023051902150749000_107.6.743.25","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(97)30084-0"},{"key":"2023051902150749000_107.6.743.26","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.21037\/apm-20-2417","article-title":"Bevacizumab as a treatment for radiation necrosis following stereotactic radiosurgery for brain metastases: clinical and radiation dosimetric impacts","volume":"10","author":"Li","year":"2021","journal-title":"Ann Palliat Med"},{"key":"2023051902150749000_107.6.743.27","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(91)90171-Y"},{"key":"2023051902150749000_107.6.743.28","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.radonc.2018.12.007","article-title":"Radiation tolerance of the optic pathway in patients treated with proton and photon radiotherapy","volume":"131","author":"Li","year":"2019","journal-title":"Radiother Oncol"},{"key":"2023051902150749000_107.6.743.29","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1002\/1097-0142(19870301)59:5<901::AID-CNCR2820590508>3.0.CO;2-M","article-title":"Sudden onset of blindness in patients treated with oral CCNU and low-dose cranial irradiation","volume":"59","author":"Wilson","year":"1987","journal-title":"Cancer"},{"key":"2023051902150749000_107.6.743.30","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/WNO.0000000000000765","article-title":"Radiation optic neuropathy after whole-brain radiation therapy","volume":"39","author":"Ferguson","year":"2019","journal-title":"J Neuroophthalmol"},{"key":"2023051902150749000_107.6.743.31","doi-asserted-by":"crossref","first-page":"NP28","DOI":"10.1177\/1120672121990570","article-title":"Necrosis of the optic nerve and chiasm with safe radiation doses: report of two rare cases","volume":"32","author":"Abri Aghdam","year":"2022","journal-title":"Eur J Ophthalmol"},{"key":"2023051902150749000_107.6.743.32","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1007\/s10147-018-1284-5","article-title":"Early intervention using high-precision radiotherapy preserved visual function for five consecutive patients with optic nerve sheath meningioma","volume":"23","author":"Inoue","year":"2018","journal-title":"Int J Clin Oncol"},{"key":"2023051902150749000_107.6.743.33","doi-asserted-by":"crossref","DOI":"10.1186\/s13014-019-1438-2","article-title":"Retrospective analysis of fractionated intensity-modulated radiotherapy (IMRT) in the interdisciplinary management of primary optic nerve sheath meningiomas","volume":"14","author":"Eckert","year":"2019","journal-title":"Radiat Oncol"},{"key":"2023051902150749000_107.6.743.34","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1007\/s00417-019-04424-w","article-title":"Efficacy of intensity-modulated radiation therapy for optic nerve sheath meningioma","volume":"257","author":"Sasano","year":"2019","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2023051902150749000_107.6.743.35","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0360-3016(89)90385-4","article-title":"Repeat megavoltage irradiation of pituitary and suprasellar tumors","volume":"17","author":"Flickinger","year":"1989","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2023051902150749000_107.6.743.36","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1148\/radiology.185.1.1523337","article-title":"Optic neuropathy after irradiation of meningioma","volume":"185","author":"Goldsmith","year":"1992","journal-title":"Radiology"},{"key":"2023051902150749000_107.6.743.37","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(97)00029-1"},{"key":"2023051902150749000_107.6.743.38","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(99)00030-9"},{"key":"2023051902150749000_107.6.743.39","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(00)01411-5"},{"key":"2023051902150749000_107.6.743.40","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2004.12.009"},{"key":"2023051902150749000_107.6.743.41","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0360-3016(01)01634-0","article-title":"Combination of photon and proton radiation therapy for chordomas and chondrosarcomas of the skull base: the centre de Protonth\u00e9rapie D'Orsay experience","volume":"51","author":"No\u00ebl","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2023051902150749000_107.6.743.42","doi-asserted-by":"publisher","DOI":"10.1148\/120.1.167"},{"key":"2023051902150749000_107.6.743.43","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1080\/01658107.2020.1817946","article-title":"Radiation-Induced optic neuropathy: literature review","volume":"45","author":"Ata\u00eddes","year":"2021","journal-title":"Neuroophthalmology"},{"key":"2023051902150749000_107.6.743.44","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1002\/pbc.25494","article-title":"Proton therapy for pediatric and adolescent esthesioneuroblastoma","volume":"62","author":"Lucas","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"2023051902150749000_107.6.743.45","doi-asserted-by":"publisher","DOI":"10.1007\/s00381-005-1188-3"},{"key":"2023051902150749000_107.6.743.46","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/WNO.0000000000000670","article-title":"Radiation-Induced optic neuropathy: clinical and imaging profile in 12 patients","volume":"39","author":"Archer","year":"2019","journal-title":"J Neuro-Ophthalmol"},{"key":"2023051902150749000_107.6.743.47","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s11060-017-2545-2","article-title":"Differentiating radiation necrosis from tumor progression in brain metastases treated with stereotactic radiotherapy: utility of intravoxel incoherent motion perfusion MRI and correlation with histopathology","volume":"134","author":"Detsky","year":"2017","journal-title":"J Neurooncol"},{"key":"2023051902150749000_107.6.743.48","first-page":"1455","article-title":"Diffusion-Weighted imaging of radiation-induced brain injury for differentiation from tumor recurrence","volume":"26","author":"Asao","year":"2005","journal-title":"AJNR Am J Neuroradiol"},{"key":"2023051902150749000_107.6.743.49","doi-asserted-by":"publisher","DOI":"10.1055\/s-2005-870952"},{"key":"2023051902150749000_107.6.743.50","first-page":"6","article-title":"Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system. Int J Radiat Oncol Biol Phys 2011;79:1487-95","volume":"84","author":"Levin","year":"2012","journal-title":"Published correction appears in Int J Radiat Oncol Biol Phys"},{"key":"2023051902150749000_107.6.743.51","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.ijrobp.2018.04.068","article-title":"Bevacizumab monotherapy reduces radiation-induced brain necrosis in nasopharyngeal carcinoma patients: a randomized controlled trial","volume":"101","author":"Xu","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2023051902150749000_107.6.743.52","first-page":"272","article-title":"A prospective, multicentre, single-arm clinical trial of bevacizumab for patients with surgically untreatable, symptomatic brain radiation necrosis\u2020","volume":"3","author":"Furuse","year":"2016","journal-title":"Neurooncol Pract"},{"key":"2023051902150749000_107.6.743.53","doi-asserted-by":"crossref","DOI":"10.3389\/fsurg.2021.720506","article-title":"Low-Dosage bevacizumab treatment: effect on radiation necrosis after gamma knife radiosurgery for brain metastases","volume":"8","author":"Weng","year":"2021","journal-title":"Front Surg"},{"key":"2023051902150749000_107.6.743.54","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.720417","article-title":"Blood-Brain barrier repair of bevacizumab and corticosteroid as prediction of clinical improvement and relapse risk in radiation-induced brain necrosis: a retrospective observational study","volume":"11","author":"Xue","year":"2021","journal-title":"Front Oncol"},{"key":"2023051902150749000_107.6.743.55","doi-asserted-by":"crossref","first-page":"8447","DOI":"10.2147\/OTT.S223258","article-title":"Ultra-low-dose bevacizumab for cerebral radiation necrosis: a prospective phase II clinical study","volume":"12","author":"Zhuang","year":"2019","journal-title":"Onco Targets Ther"},{"key":"2023051902150749000_107.6.743.56","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-021-07889-3","article-title":"Bevacizumab for radiation necrosis following radiotherapy of brain metastatic disease: a systematic review & meta-analysis","volume":"21","author":"Khan","year":"2021","journal-title":"BMC Cancer"},{"key":"2023051902150749000_107.6.743.57","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/WNO.0b013e3182607381","article-title":"Novel treatment for radiation optic neuropathy with intravenous bevacizumab","volume":"32","author":"Farooq","year":"2012","journal-title":"J Neuroophthalmol"},{"key":"2023051902150749000_107.6.743.58","doi-asserted-by":"crossref","DOI":"10.1016\/j.wneu.2017.07.111","article-title":"Bevacizumab for radiation induced optic neuritis among aggressive residual\/recurrent suprasellar tumors: more than a mere antineoplastic effect","volume":"107","author":"Dutta","year":"2017","journal-title":"World Neurosurg"},{"key":"2023051902150749000_107.6.743.59","first-page":"1217","article-title":"Intravitreal bevacizumab for delayed radiation maculopathy and papillopathy after irradiation for maxillary sinus cancer","volume":"5","author":"Gondo","year":"2011","journal-title":"Clin Ophthalmol"},{"key":"2023051902150749000_107.6.743.60","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ajo.2019.07.004","article-title":"Radiation-Induced optic neuropathy: observation versus intravitreal treatment: can visual acuity be maintained by intravitreal treatment?","volume":"208","author":"Eckstein","year":"2019","journal-title":"Am J Ophthalmol"},{"key":"2023051902150749000_107.6.743.61","doi-asserted-by":"crossref","first-page":"50","DOI":"10.21037\/cco.2016.07.06","article-title":"Proton therapy for the management of uveal melanoma and other ocular tumors","volume":"5","author":"Mishra","year":"2016","journal-title":"Chin Clin Oncol"},{"key":"2023051902150749000_107.6.743.62","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0161-6420(86)33617-0","article-title":"Hyperbaric oxygen in the treatment of radiation-induced optic neuropathy","volume":"93","author":"Guy","year":"1986","journal-title":"Ophthalmology"},{"key":"2023051902150749000_107.6.743.63","first-page":"98","article-title":"Visual recovery from radiation-induced optic neuropathy. The role of hyperbaric oxygen therapy","volume":"13","author":"Borruat","year":"1993","journal-title":"J Clin Neuroophthalmol"},{"key":"2023051902150749000_107.6.743.64","doi-asserted-by":"publisher","DOI":"10.1530\/eje.1.02161"},{"key":"2023051902150749000_107.6.743.65","doi-asserted-by":"crossref","first-page":"4213","DOI":"10.1007\/s00520-019-04699-z","article-title":"Predictors of the therapeutic effect of corticosteroids on radiation-induced optic neuropathy following nasopharyngeal carcinoma","volume":"27","author":"Zheng","year":"2019","journal-title":"Support Care Cancer"},{"key":"2023051902150749000_107.6.743.66","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/WNO.0b013e318276d4b8","article-title":"Is pentoxifylline plus vitamin E an effective treatment for radiation-induced optic neuropathy?","volume":"33","author":"Chahal","year":"2013","journal-title":"J Neuroophthalmol"},{"key":"2023051902150749000_107.6.743.67","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.06.064"},{"key":"2023051902150749000_107.6.743.68","doi-asserted-by":"crossref","first-page":"e210","DOI":"10.1016\/j.wneu.2020.08.081","article-title":"A comparison of ramipril and bevacizumab to mitigate radiation-induced brain necrosis: an experimental study","volume":"144","author":"Erpolat","year":"2020","journal-title":"World Neurosurg"},{"key":"2023051902150749000_107.6.743.69","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ophtha.2013.08.039","article-title":"Intravitreal bevacizumab at 4-month intervals for prevention of macular edema after plaque radiotherapy of uveal melanoma","volume":"121","author":"Shah","year":"2014","journal-title":"Ophthalmology"},{"key":"2023051902150749000_107.6.743.70","doi-asserted-by":"crossref","DOI":"10.1177\/11206721221085409","article-title":"Treatment and prophylaxis of radiation optic neuropathy: a systematic review and meta-analysis","volume":"32","author":"Yu","year":"2022","journal-title":"Eur J Ophthalmol"}],"container-title":["British Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bjo-2022-322854","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T09:18:15Z","timestamp":1684487895000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjo.bmj.com\/lookup\/doi\/10.1136\/bjo-2022-322854"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,23]]},"references-count":70,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,5,19]]},"published-print":{"date-parts":[[2023,6]]}},"alternative-id":["10.1136\/bjo-2022-322854"],"URL":"https:\/\/doi.org\/10.1136\/bjo-2022-322854","relation":{},"ISSN":["0007-1161","1468-2079"],"issn-type":[{"value":"0007-1161","type":"print"},{"value":"1468-2079","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,23]]}}}